These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8057989)

  • 21. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
    Garland J; Buck R; Weinberg M
    Pediatrics; 1994 Nov; 94(5):719-23. PubMed ID: 7936902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants.
    Sharma P; McKay K; Rosenkrantz TS; Hussain N
    BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants.
    Sitler CG; Turnage CS; McFadden BE; Smith EO; Adams JM
    J Perinatol; 1993; 13(3):197-200. PubMed ID: 8345382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
    Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
    Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
    J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants.
    Bhandari V; Bergqvist LL; Kronsberg SS; Barton BA; Anand KJ;
    Pediatrics; 2005 Aug; 116(2):352-9. PubMed ID: 16061589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.